Pathogenesis of pseudohypoaldosteronism type 2 by WNK1 mutations.

@article{Bergaya2012PathogenesisOP,
  title={Pathogenesis of pseudohypoaldosteronism type 2 by WNK1 mutations.},
  author={Sonia Bergaya and Emmanuelle Vidal-Petiot and Xavier Jeunema{\^i}tre and Juliette Hadchouel},
  journal={Current opinion in nephrology and hypertension},
  year={2012},
  volume={21 1},
  pages={
          39-45
        }
}
PURPOSE OF REVIEW Pseudohypoaldosteronism type 2 (PHA2) is a rare autosomal dominant form of human arterial hypertension, associated with hyperkalemia and hyperchloremic metabolic acidosis. WNK1 and WNK4 are two of the genes mutated in PHA2 patients. This review focuses on the mechanisms by which deletions of the first intron of WNK1 found in PHA2 patients trigger the disease. RECENT FINDINGS The WNK1 gene gives rise to a ubiquitous kinase (L-WNK1) and to a shorter kinase-defective isoform… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 13 CITATIONS

Hypertension: the missing WNKs.

  • American journal of physiology. Renal physiology
  • 2016
VIEW 11 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

WNK3 abrogates the NEDD4-2-mediated inhibition of the renal Na+-Cl- cotransporter.

  • American journal of physiology. Renal physiology
  • 2014
VIEW 1 EXCERPT
CITES BACKGROUND

Similar Papers

Loading similar papers…